Clinical Trials Patients State Laws Treatment 
Cannabis Law Report
OCTOBER 4, 2021
One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions.
Canna Law Blog
NOVEMBER 10, 2020
Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. Right to Try was first introduced as state legislation, with similar laws in 41 states (the federal law does not contain preemption language).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TheAnswerPage
JANUARY 11, 2022
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
MMJ Recs
MAY 9, 2024
In this instance, medical cannabis offers a promising alternative or complementary treatment option. There are multiple US states with an established state-approved medical marijuana program as well as states permitting the use of cannabinol (CBD) oil – a non-psychoactive component of cannabis – for medical purposes exclusively.
MMJ Recs
DECEMBER 17, 2023
The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.
Cannabis Law Report
APRIL 21, 2022
Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). About MAPS Public Benefit Corporation (MAPS PBC). Key Responsibilities.
Veriheal
NOVEMBER 17, 2020
Advocates have tried to make this happen in the past partitioning for the addition of these three conditions, but they were ultimately denied by the state’s medical review board. In regard to the petition to add these three conditions to state law, advocates must be very careful. Anup Patel is the most perplexing.
Expert insights. Personalized for you.
52 
Let's personalize your content